Fortress Biotech Inc (FBIO) Stock Price, Quote & News

Company Profile

Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-n...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 652 4500

Website: www.fortressbiotech.com

Address:

1111 Kane Concourse, Suite 301, Bay Harbor Islands, United States

KeepYourDayJob Feb. 23 at 3:00 PM

$FBIO LOVE HOW THEY ALWAYS LAG HERE WHEN ITS UP!

0 · Reply

Biostock Feb. 23 at 2:59 PM

$FBIO send it to 7. Trading below cash. $SPY $QQQ

0 · Reply

notreload_ai Feb. 23 at 2:55 PM

$FBIO Cyprium Therapeutics (Fortress Biotech subsidiary) just signed a deal to sell its Rare Pediatric Disease Priority Review Voucher for $205M after FDA approval of ZYCUBO for Menkes disease. https://notreload.xyz/fortress-biotech-sells-prv-for-205m-after-zycubo-approval/

0 · Reply

kebrik Feb. 23 at 2:54 PM

Today's movers: $CETY, $YMAT, $GFAI, $FBIO, and $BDMD

0 · Reply

daniel6452 Feb. 23 at 2:49 PM

$FBIO I'm in

0 · Reply

DirkInvest Feb. 23 at 2:44 PM

$FBIO Finally over $4! At last some action, don't know why it took so long but I gathered some more shares. I expect $5 min by the end of the week.

1 · Reply

Sawnchey Feb. 23 at 2:44 PM

$FBIO $FBIOP Below is the segment report from the latest 10-Q published November 14th. On that day the stock price was 2.62. In the 10-Q to be published in May: the following is likely to be different: 1: The Pink Highlight is likely to be a profit, rather than a loss. 2: The Yellow Highlight will likely be somewhere in the rigion of 140 Million dollars. 3: The Green Highlight will likely have a number above 100 Million dollars. So +50% on the common stock since then doesn’t sound like the correct number!

0 · Reply

Abelvskane Feb. 23 at 2:35 PM

$FBIO $FBIO The only ticker that looked promising this morning and I didn’t pull the trigger at 3.38. Of course 😭

0 · Reply

Bangerstocksbuyer Feb. 23 at 2:33 PM

$FBIO Why is it not flying??

1 · Reply

drose0527 Feb. 23 at 2:23 PM

$FBIO fuck I wanted to buy more today I had 5,000 to roll in here today! Damn it was hoping it would be 1-2 days to get to build my position again today

0 · Reply

UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

FBIO

Feb 23, 2026, 8:30 AM EST - 1 hour ago

Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

FBIO

Feb 23, 2026, 8:00 AM EST - 1 hour ago

Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease

FBIO

Feb 19, 2026, 9:38 PM EST - 3 days ago

Fortress Biotech: The PRV Catalyst That Could Reprice This Microcap

FBIO

Jan 13, 2026, 7:45 AM EST - 5 weeks ago

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States

FBIO

Dec 15, 2025, 8:00 AM EST - 2 months ago

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission

FBIO

Dec 10, 2025, 8:30 AM EST - 2 months ago

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology

DERM FBIO

Nov 14, 2025, 8:30 AM EST - 3 months ago

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

FBIO

Nov 12, 2025, 10:41 PM EST - 3 months ago

Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript

FBIO

Nov 12, 2025, 4:01 PM EST - 3 months ago

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

DERM FBIO

Nov 6, 2025, 7:00 AM EST - 3 months ago

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

AXSM FBIO

Nov 5, 2025, 8:30 AM EST - 3 months ago

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

DERM FBIO

Oct 24, 2025, 8:30 AM EDT - 4 months ago

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

DERM FBIO

Oct 21, 2025, 8:30 AM EDT - 4 months ago

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics' Global Phase 3 Trials of Dotinurad for the Treatment of Gout

FBIO

Oct 8, 2025, 8:30 AM EDT - 4 months ago

Journey Medical Corporation to Participate in October 2025 Investor Conferences

DERM FBIO

Oct 1, 2025, 3:45 PM EDT - 5 months ago

Fortress Biotech Investigated by the Portnoy Law Firm

FBIO

Oct 1, 2025, 8:05 AM EDT - 5 months ago

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics' $205 Million Series A Financing

FBIO

Oct 1, 2025, 8:00 AM EDT - 5 months ago

Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101

FBIO

Sep 3, 2025, 8:30 AM EDT - 6 months ago

Journey Medical Corporation to Participate in September 2025 Investor Conferences

DERM FBIO

Sep 2, 2025, 8:30 AM EDT - 6 months ago

Fortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference

FBIO

Aug 18, 2025, 8:30 AM EDT - 6 months ago

Journey Medical Corporation to Present at the Emerging Growth Conference

DERM FBIO

Aug 14, 2025, 4:05 PM EDT - 6 months ago

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

FBIO

Aug 12, 2025, 4:01 PM EDT - 6 months ago

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

DERM FBIO

Aug 7, 2025, 8:30 AM EDT - 7 months ago

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

DERM FBIO

Aug 5, 2025, 4:01 PM EDT - 7 months ago

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

DERM FBIO

Jul 14, 2025, 8:30 AM EDT - 8 months ago

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

DERM FBIO

Jun 24, 2025, 8:30 AM EDT - 8 months ago

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

DERM FBIO

Jun 20, 2025, 8:30 AM EDT - 8 months ago

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

DERM FBIO

Jun 9, 2025, 8:30 AM EDT - 9 months ago

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

DERM FBIO

May 30, 2025, 10:47 AM EDT - 9 months ago

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

FBIO

May 15, 2025, 4:05 PM EDT - 10 months ago

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

FBIO

May 14, 2025, 4:01 PM EDT - 10 months ago

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

DERM FBIO

May 13, 2025, 4:15 PM EDT - 10 months ago

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates

CKPT FBIO

May 7, 2025, 4:01 PM EDT - 10 months ago

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

DERM FBIO

May 7, 2025, 8:00 AM EDT - 10 months ago

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference

FBIO

Apr 1, 2025, 4:01 PM EDT - 11 months ago

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

DERM FBIO

Mar 31, 2025, 4:05 PM EDT - 11 months ago

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

FBIO

Mar 28, 2025, 8:30 AM EDT - 11 months ago

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

CKPT FBIO

Mar 26, 2025, 7:39 PM EDT - 11 months ago

Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call Transcript

FBIO

Mar 26, 2025, 4:01 PM EDT - 11 months ago

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

DERM FBIO

Mar 24, 2025, 8:30 AM EDT - 1 year ago

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

DERM FBIO

Mar 19, 2025, 4:01 PM EDT - 1 year ago

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

DERM FBIO

Mar 17, 2025, 8:55 AM EDT - 1 year ago

Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform

FBIO

Mar 12, 2025, 8:30 AM EDT - 1 year ago

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

DERM FBIO

Mar 9, 2025, 10:06 PM EDT - 1 year ago

Sun Pharma to Acquire Checkpoint Therapeutics

CKPT FBIO

Mar 5, 2025, 4:15 PM EST - 1 year ago

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

FBIO MBIO

Mar 5, 2025, 4:01 PM EST - 1 year ago

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

DERM FBIO

KeepYourDayJob Feb. 23 at 3:00 PM

$FBIO LOVE HOW THEY ALWAYS LAG HERE WHEN ITS UP!

0 · Reply

Biostock Feb. 23 at 2:59 PM

$FBIO send it to 7. Trading below cash. $SPY $QQQ

0 · Reply

notreload_ai Feb. 23 at 2:55 PM

0 · Reply

kebrik Feb. 23 at 2:54 PM

Today's movers: $CETY, $YMAT, $GFAI, $FBIO, and $BDMD

0 · Reply

daniel6452 Feb. 23 at 2:49 PM

$FBIO I'm in

0 · Reply

DirkInvest Feb. 23 at 2:44 PM

$FBIO Finally over $4! At last some action, don't know why it took so long but I gathered some more shares. I expect $5 min by the end of the week.

1 · Reply

Sawnchey Feb. 23 at 2:44 PM

0 · Reply

Abelvskane Feb. 23 at 2:35 PM

$FBIO $FBIO The only ticker that looked promising this morning and I didn’t pull the trigger at 3.38. Of course 😭

0 · Reply

Bangerstocksbuyer Feb. 23 at 2:33 PM

$FBIO Why is it not flying??

1 · Reply

drose0527 Feb. 23 at 2:23 PM

$FBIO fuck I wanted to buy more today I had 5,000 to roll in here today! Damn it was hoping it would be 1-2 days to get to build my position again today

0 · Reply

braves1983 Feb. 23 at 2:22 PM

$FBIO still 3.42 on Stocktwits. Why? Glitch?

1 · Reply

buymoremakemore Feb. 23 at 2:21 PM

$FBIO Im happy theyre advancing the gene therapy for menkes with the prv money. That could create a BO scenario if data is good.

0 · Reply

PSM_EmpowerTrading Feb. 23 at 2:20 PM

🌅 Watchlist PART 2 ✅ $SGN mid $0.55 support, if above $0.70, have potential to $0.80 / $0.85 ✅ $VHUB low $2 support, if above $2.50, have potential to $2.70 / $2.80 ✅ $RXT ideal if above $2 support ✅ $FBIO mid $3.50 support, if above $4.00, have potential to $4.50 / $4.70 ✅ $IBRX mid $9.50 support, if above $10.00, have potential to $10.50 / $11.00 🚨 The above tickers are not ideal for swing accumulation at current price ✅ Ideal long entry near low current support. 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D

0 · Reply

GSP Feb. 23 at 2:20 PM

$GETY $LEGN $FBIO

0 · Reply

JigarJigar Feb. 23 at 2:19 PM

$FBIO super

0 · Reply

StockSenseiTrendTraders Feb. 23 at 2:19 PM

Watching these for market open for a setup to form: $EZRA $RXT $FBIO $SGN

0 · Reply

braves1983 Feb. 23 at 2:16 PM

$FBIO this should be over $5 and headed to $7 and yet still under $4 with over 7 million in volume in premarket. Make it make sense

1 · Reply

Rampageusa Feb. 23 at 2:14 PM

$FBIO 4/4.95/5.5 in steps

0 · Reply

braves1983 Feb. 23 at 2:14 PM

$FBIO already down 40 cents. So pump and dump. 7 million in volume already….. and falling. Touches around 4.15 and now 3.80. Every time I think this is it finally, it’s a pump fake

0 · Reply

GSP Feb. 23 at 2:11 PM

Updated gapper list (con't): $GETY $LEGN $FBIO .

0 · Reply

tennant Feb. 23 at 2:10 PM

$FBIO https://www.fortressbiotech.com/news-media/press-releases/detail/732/fortress-biotechs-subsidiary-cyprium-therapeutics-enters

0 · Reply

Stock_Catcher Feb. 23 at 2:09 PM

Great Moves Money Monday Morning for my Team 💵 $TIRX 164% Gainer , Drew out levels step by step $ALUR Posted news right at start FDA Approval 82% $FBIO Bounce off my base levels shown on screen 22% $GETY My Voice News Scanner Caught very early 40% $SGN Continuation multi swing up nice % If you want Breaking News +Fast Voice Alerts +Price Action Analysis +Scanners+ Day Trading+Swing Trading+ Technical analysis focus, Link to join. Massive Trading Community only Growing every Month. https://www.youtube.com/channel/UCwfLAT9kO2JU-BhoYxGDnrA/join

0 · Reply

Market Cap	104.29M
Revenue (ttm)	57.68M
Net Income (ttm)	-46.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	5.61
Profit Margin	-79.75%
Debt to Equity Ratio	0.73

Volume	291,700
Avg Vol	826,006
Day's Range	N/A - N/A
Shares Out	31.04M
Stochastic %K	17%
Beta	1.43
Analysts	Strong Sell
Price Target	$10.75